文献速递胸部肿瘤放疗放疗物理与技术

肺癌胸部再程放疗中重度放射性肺炎的风险与预测因素

The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
PubMed 文献 · Radiat Oncol · 2018-04-16

18例(26.9%)发生≥3级放射性肺炎(17例3级,1例4级)。多因素分析显示,初程放疗计划MLD、复合计划V5及overlap-V5/re-V5是独立预测因素;在部分病例中,野外失败相比野内失败与更高的重度放射性肺炎风险相关。

要点

  • 再程放疗后≥3级放射性肺炎发生率为26.9%。
  • 初程MLD、复合计划V5及overlap-V5/re-V5为独立预测因素。
  • 部分病例中野外失败较野内失败的重度放射性肺炎风险更高。

核心结论

  • ≥3级放射性肺炎的风险不仅可由再程放疗计划的剂量体积变量预测,也可由初程放疗计划和复合计划的某些变量预测。
  • 在部分病例中,野外失败相比野内失败与更高的重度放射性肺炎风险相关。

研究设计与样本

  • 60例采用三维适形放疗/调强放疗,7例采用立体定向体部放疗。
  • 采用可变形图像配准生成复合计划,按CTCAE 4.0版分级≥3级放射性肺炎。

主要发现

  • 18例(26.9%)发生≥3级放射性肺炎,其中17例为3级、1例为4级。
  • 单因素分析中,初程或再程计划的V5和MLD、复合计划的V5和V20、以及初程V5与再程V5的重叠比例(overlap-V5/re-V5)均与≥3级放射性肺炎显著相关(每项比较P<0.05)。
  • 多因素分析显示,初程放疗计划MLD(HR=14.515,95%CI:1.778-118.494,P=0.013)、复合计划V5(HR=7.398,95%CI:1.319-41.495,P=0.023)及overlap-V5/re-V5(P=0.041)是≥3级放射性肺炎的独立预测因素。
  • 野外失败且overlap-V5/re-V5为0.4-0.8者,相比野内失败者≥3级放射性肺炎风险更高(18.3% vs. 50%,P=0.014)。

关键数值与推荐

  • ≥3级放射性肺炎按CTCAE 4.0版分级。
  • 多因素分析中初程MLD的HR=14.515(95%CI:1.778-118.494,P=0.013)。
  • 复合计划V5的HR=7.398(95%CI:1.319-41.495,P=0.023)。
  • overlap-V5/re-V5的P=0.041。
  • 野外失败且overlap-V5/re-V5为0.4-0.8者≥3级放射性肺炎发生率为50%,野内失败者为18.3%(P=0.014)。

临床怎么用

  • 制定再程放疗计划时,应综合评估初程放疗计划的MLD、复合计划的V5以及初程与再程V5的重叠比例,以预测重度放射性肺炎风险。
  • 对于野外失败且overlap-V5/re-V5处于0.4-0.8的患者,需警惕更高的重度放射性肺炎风险。

局限性

  • 原文未报告研究设计类型(回顾性或前瞻性)及样本量计算依据。
  • 原文未报告随访时长、毒性评估时间窗及多因素模型校正的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic reirradiation (re-RT) is increasingly administered. However, radiation pneumonitis (RP) remains to be the most common side effect from retreatment. This study aimed to determine the risk and predictors for severe RP in patients receiving thoracic re-RT. METHODS: Sixty seven patients with lung cancer received thoracic re-RT for recurrent or metastatic disease. Three-dimensional conformal radiotherapy (3D-CRT)/intensity modulated radiotherapy (IMRT) was used for 60 patients, and stereotactic body radiation therapy (SBRT) was used in 7 patients. Deformable image registration (DIR) was performed to create a composite plan. Severe (grade ≥ 3) RP was graded according to Common Terminology Criteria for Adverse Events version 4.0. RESULTS: Eighteen patients (26.9%) developed grade ≥ 3 RP (17 of grade 3, and 1 of grade 4). In univariate analyses, V5 and mean lung dose (MLD) of initial RT or re-RT plans, V5 and V20 of composite plans, and the overlap between V5 of initial RT and V5 of re-RT plans/V5 of re-RT plans (overlap-V5/re-V5) were significantly associated with grade ≥ 3 RP (P < 0.05 for each comparison). Multivariate analysis revealed that MLD of the initial RT plans (HR = 14.515, 95%CI:1.778-118.494, P = 0.013), V5 of the composite plans (HR = 7.398, 95%CI:1.319-41.495, P = 0.023), and overlap-V5/re-V5 (P = 0.041) were independent predictors for grade ≥ 3 RP. Out-of-field failures with medium overlap-V5/re-V5 of 0.4-0.8 was associated with higher risk of grade ≥ 3 RP compared with in-field failures (18.3% vs. 50%, P = 0.014). CONCLUSIONS: The risk of grade ≥ 3 RP could be predicted not only by dose-volume variables from re-RT plan, but also by some from initial-RT and composite plans. Out-of-field failures was associated with higher risk of severe RP compared with in-field failures in some cases.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ren C, Ji T, Liu T, et al. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation. Radiat Oncol. 2018. PMID: 29661254. doi:10.1186/s13014-018-1016-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。